These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8063398)
21. [Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica]. Xue Y; Zhao Z; Pei J; Wang C; Ding K; Cheng X Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1722-8. PubMed ID: 22506412 [TBL] [Abstract][Full Text] [Related]
22. Genomics of Bordetella pertussis toxins. Antoine R; Raze D; Locht C Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902 [TBL] [Abstract][Full Text] [Related]
23. Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida. Kimman TG; Löwik CW; van de Wee-Pals LJ; Thesingh CW; Defize P; Kamp EM; Bijvoet OL Infect Immun; 1987 Sep; 55(9):2110-6. PubMed ID: 3623695 [TBL] [Abstract][Full Text] [Related]
24. Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Hausman SZ; Cherry JD; Heininger U; Wirsing von König CH; Burns DL Infect Immun; 1996 Oct; 64(10):4020-6. PubMed ID: 8926063 [TBL] [Abstract][Full Text] [Related]
25. Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models. Zhang Y; Lin L; Yang J; Lv Q; Wang M; Wang F; Huang X; Hua L; Wang X; Chen H; Wilson BA; Wu B; Peng Z Vaccine; 2022 Jun; 40(27):3771-3780. PubMed ID: 35599036 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms influencing expression of dermonecrotic toxin in Bordetella bronchiseptica. Okada K; Abe H; Ike F; Ogura Y; Hayashi T; Fukui-Miyazaki A; Nakamura K; Shinzawa N; Horiguchi Y PLoS One; 2015; 10(2):e0116604. PubMed ID: 25642712 [TBL] [Abstract][Full Text] [Related]
27. Molecular aspects of Bordetella pertussis pathogenesis. Locht C Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406 [TBL] [Abstract][Full Text] [Related]
28. The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. van der Zee A; Groenendijk H; Peeters M; Mooi FR Int J Syst Bacteriol; 1996 Jul; 46(3):640-7. PubMed ID: 8782670 [TBL] [Abstract][Full Text] [Related]
29. Identification of functional domains of Bordetella dermonecrotizing toxin. Kashimoto T; Katahira J; Cornejo WR; Masuda M; Fukuoh A; Matsuzawa T; Ohnishi T; Horiguchi Y Infect Immun; 1999 Aug; 67(8):3727-32. PubMed ID: 10417130 [TBL] [Abstract][Full Text] [Related]
31. Evolutionary relationships in the genus Bordetella. Aricò B; Gross R; Smida J; Rappuoli R Mol Microbiol; 1987 Nov; 1(3):301-8. PubMed ID: 2896289 [TBL] [Abstract][Full Text] [Related]
32. Intracellular locations of dermonecrotic toxins in Pasteurella multocida and in Bordetella bronchiseptica. Nakai T; Sawata A; Kume K Am J Vet Res; 1985 Apr; 46(4):870-4. PubMed ID: 4014837 [TBL] [Abstract][Full Text] [Related]
33. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin. Matsuzawa T; Kashimoto T; Katahira J; Horiguchi Y Infect Immun; 2002 Jul; 70(7):3427-32. PubMed ID: 12065482 [TBL] [Abstract][Full Text] [Related]
34. Production of Highly Active Recombinant Dermonecrotic Toxin of Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577 [TBL] [Abstract][Full Text] [Related]
35. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. Ohnishi T; Horiguchi Y; Masuda M; Sugimoto N; Matsuda M J Vet Med Sci; 1998 Mar; 60(3):301-5. PubMed ID: 9560776 [TBL] [Abstract][Full Text] [Related]
36. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties. Munro P; Flatau G; Anjuère F; Hofman V; Czerkinsky C; Lemichez E Vaccine; 2005 Apr; 23(20):2551-6. PubMed ID: 15780436 [TBL] [Abstract][Full Text] [Related]
37. Identification of a Bordetella pertussis regulatory factor required for transcription of the pertussis toxin operon in Escherichia coli. DeShazer D; Wood GE; Friedman RL J Bacteriol; 1995 Jul; 177(13):3801-7. PubMed ID: 7601846 [TBL] [Abstract][Full Text] [Related]
38. Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Szymkowicz L; Gerard J; Messham B; Tam WWV; James DA Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822547 [TBL] [Abstract][Full Text] [Related]
39. Cloning and expression of the dermonecrotic toxin gene of Pasteurella multocida ssp. multocida in Escherichia coli. Kamps AM; Kamp EM; Smits MA FEMS Microbiol Lett; 1990 Jan; 55(1-2):187-90. PubMed ID: 2328908 [TBL] [Abstract][Full Text] [Related]